Testicular vasculitis: a series of 19 cases by Billis, Athanase
279
Urological Survey
T1c, prostate-specific antigen density < 0.15 ng/mL, Gleason score ≤ 6, two or fewer cores with cancer, and ≤ 
50% cancer involvement of any core.
 During the follow-up period the proportions of men who underwent curative intervention (p = 0.026) 
or had biopsy reclassification (more than 2 cores, Gleason score > 6, or > 50% cancer involvement of any core) 
(p < 0.001) were significantly lower in men who met very-low-risk criteria. There were also no prostate cancer 
deaths in this cohort of patients.
 The authors conclude that for carefully selected men, active surveillance limited to patients with very-
low-risk cancers according to Epstein’s criteria for insignificant cancer may significantly reduce the frequency 
of adverse outcomes.
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Objectives: Because of limited reported cases, it is unknown how often testicular vasculitis represents isolated 
or systemic disease.
Methods: We report 19 cases (15 consultation; 4 in-house cases) of localized testicular infarction with associated 
vasculitis spanning 24 years.
Results: All were orchiectomy specimens; detailed clinical information was available in 16 cases. Mean age was 
38 years. Clinical presentation was testicular pain in 13 and mass in 3 patients. Preoperative impression was 
testicular cancer in 13 cases. In all cases, localized testicular infarction associated with vasculitis was present 
and in none was tumor identified. Most cases (n = 14) showed polyarteritis nodosa (PAN)-like features with 
transmural necrotizing inflammation of small-medium arteries. In 4 cases, vasculitis was granulomatous (2 
necrotizing; 2 non-necrotizing) and in 1 case was lymphocytic. An infectious etiology was excluded clinically 
and by special stains. Four patients were subsequently confirmed with systemic vaculitis: one with PAN, one 
with Wegener vasculitis, one with vasculitis not otherwise specified and one with subclinical systemic vasculitis. 
Two of those 4 patients had testicular PAN-like vasculitis and 2 had granulomatous vasculitis.
Conclusions: Testicular vasculitis can cause localized infarction that clinically mimics cancer. Although testi-
cular vasculitis is an isolated finding in most patients an associated systemic vasculitis is not a rare event (4/16, 
or 25%), especially if the vasculitis is granulomatous (50% in this series). All patients should be clinically 




 This is a large series of a rare condition in the testis. Testicular vasculitis can cause localized infarc-
tion that clinically may mimic cancer (1). Testicular vasculitis may be an isolated finding, however, in most 
patients is associated with systemic vasculitis. All patients should be clinically investigated for systemic disease. 
In this series of 19 cases the mean age was 38 years and most cases (n = 14) showed polyarteritis nodosa-like 
features with transmural necrotizing inflammation of small-medium arteries (2). The pathologist must be aware 
of this condition and look for vasculitis whenever a patient with an infarcted testis has no history of torsion or 
trauma.
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Background: Observational studies suggest a proportion of patients with lymph node metastases will benefit 
from lymph node dissection (LND) at the time of nephrectomy for clear cell renal cell carcinoma (RCC).
Objective: Our aim was to report the performance of five previously identified high-risk pathologic features as-
sessed by intraoperative examination on prediction of lymph node metastases and propose a template for LND 
based on locations of lymph node involvement.
Design, Setting, and Participants: The study included a historical cohort of consecutive patients from a single 
institution who received LND in conjunction with nephrectomy for high-risk clear cell RCC between 2002 and 
2006.
Interventions: All patients underwent nephrectomy and LND.
Measurements: Patients were considered high risk for nodal metastasis if two or more of the following features 
were identified during intraoperative pathologic assessment of the primary tumor: nuclear grade 3 or 4, sarco-
matoid component, tumor size ≥10cm, tumor stage pT3 or pT4, or coagulative tumor necrosis. Based on these 
